Healthcare Realty Trust Inc (HR): Results of Operations and Financial Condition
Healthcare Realty Trust Inc (HR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.2 3 exhibit992supplementalinfo.htm EX-99.2 Document 2Q 2026 Supplemental Information FURNISHED AS OF JULY 30, 2026 (UNAUDITED) Table of Contents FORWARD LOOKING STATEMENTS & RISK FACTORS This Supplemental Information report contains disclosures that are “forward-looking sta
How this was made
The 30-second read
Why it matters
Traders can update valuation models using the raised 2026 Normalized FFO and same-store cash NOI growth guidance, and reassess near-term leverage and interest expense implications from the new exchangeable notes and delayed draw term loan.
Market read
Raised full-year guidance ranges plus active refinancing and share repurchases are the core tradable catalysts in this filing.
What to watch
Run-rate net debt to adjusted EBITDA is 5.6x, and the guidance is still exposed to tenant reimbursement regulation and lease renewal/space release execution risk.
Background
The company filed an SEC 8-K with 2Q 2026 supplemental information, including earnings highlights, full-year guidance, and capital allocation updates.
Ticker impact
Healthcare Realty Trust raised 2026 Normalized FFO guidance to $1.62-$1.66 and Same Store Cash NOI growth to 4.25%-5.00%.
Moderately positive bias for the next session and into the next earnings/guidance check, assuming no offsetting tenant or credit deterioration.
The filing is a fresh 8-K with updated full-year guidance ranges and specific capital allocation actions, which typically reprice REIT earnings power and leverage expectations.
Market effects
Reinforces the healthcare REIT theme that rent/NOI growth and leasing spreads can support higher FFO guidance despite interest-rate and tenant reimbursement risks.
Limited direct regional spillover; highlights leasing and occupancy across multiple healthcare systems.
Low; primarily company-specific guidance and financing actions.
Counterpoint
GAAP net loss persists (-$0.13/share), so the market may discount guidance if investors focus on earnings quality or leverage/interest-rate sensitivity.
Key entities
- issuerHealthcare Realty Trust Incorporated
Subject of the 8-K, reporting 2Q 2026 results and increased 2026 guidance, plus financing and capital allocation actions.
- joint_venture_partnerKKR joint venture
The filing references joint venture acquisitions closed or under contract since last quarter.

